Monday, September 14, 2026

2026 Asian Games: Can Korea’s Badminton Stars Repeat Their Medal Success?

The 2018 Asian Games marked a dark chapter for Korean badminton, as it ended with no medals for the first time in 40 years.

AI Competition Heats Up: South Korea’s Regulatory Hurdles vs. U.S. and China’s Dominance

The U.S. and China enhance AI capabilities with government support, while South Korea faces uncertainty due to AI regulations.

Xenovax PCM4: The Next-Gen Vaccine Transforming Pig Farming in Asia – Find Out How!

CARESIDE's swine vaccine technology certified as New Excellent Technology, enhancing protection and reducing farmer labor demands.

Tag: Lirafugratinib

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.